Piper Sandler analyst Jason Bednar assigned a Buy rating to Beyond Air (XAIR – Research Report) today and set a price target of $1.00.

Thibault covers the Healthcare sector, focusing on stocks such as Masimo, Abbott Laboratories ... Beyond Air (XAIR) Company Description: Beyond Air, Inc. is a clinical-stage medical device and ...

Gilero started as an engineering design firm focused on single-use medical devices and expanded to designing, developing and ...

Cardiologists from BIDMC, commissioned by the FDA, examined trends in the use and long-term safety of a device for treating ...

A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment ...

The Horizon Inspire System. [Image courtesy of Magstim] Magstim announced today that the FDA cleared its next-generation ...

Philips has now developed a device intended to integrate two forms of laser-based PAD therapy, atherectomy and intravascular ...

Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the ...